Категорије
Чланци
Здравље црева Тумачење лабораторијских налаза Ажурирање за 2026. годину Прилагођено пацијентима

Oba testa otkrivaju crevnu upalu pokrenutu neutrofilima, ali je kalprotektin obično korisniji alat za kvantitativno praćenje. Pravi rezultat je onaj koji menja sledeću kliničku odluku – a ne onaj koji vas etiketira sa IBD.

📖 ~11 минута 📅
📝 Објављено: 🩺 Медицински прегледано: ✅ Засновано на доказима
⚡ Брзи резиме v1.0 —
  1. Kalprotektin ispod 50 µg/g je generalno umirujuće kod odraslih sa sumnjom na IBS kada nema alarmantnih simptoma.
  2. Laktoferin je neutrofilni protein; mnogi kvantitativni testovi koriste vrednost manju od 7.25 µg/g kao negativnu, ali laboratorijske granične vrednosti variraju.
  3. Visoki markeri u stolici ukazuju na crevnu upalu, a ne na specifičnu dijagnozu; infekcija, NSAIL, divertikulitis i kolorektalna neoplazija mogu povisiti oba.
  4. Гранични калпротектин od 50–150 µg/g često opravdavaju ponovljeno uzimanje uzorka nakon 2–6 nedelja umesto trenutne kolonoskopije.
  5. Kalprotektin iznad 250 µg/g povećava zabrinutost za aktivnu upalu sluznice i obično podstiče klinički pregled, testiranje stolice na infekciju ili planiranje endoskopije.
  6. Нормални резултати čine aktivne kolitis IBD manje verovatnim, ali ne mogu pouzdano isključiti izolovanu bolest tankog creva (Crohnova bolest).
  7. praćenje IBD koristi simptome plus biomarkere, CRP, markere anemije, snimanje i endoskopiju; nijedan marker stolice samostalno ne dijagnostikuje upalu.
  8. Хитни симптоми kao što su crna stolica, uporna vidljiva krv, groznica, jak bol, nesvestica ili dehidracija zahtevaju lekarski pregled bez obzira na rezultat markera.

Koji test stolice biste trebali prvo odabrati?

Fekalni kalprotektin je obično marker upale stolice prve linije jer je široko dostupan, kvantitativan i ima najjaču ulogu u odvajanju verovatne zapaljenske bolesti creva od funkcionalnih crevnih simptoma. Test fekalne laktoferina rezultati su razumna alternativa kada je to lokalno validovana analiza, ali naručivanje obe analize na početku retko menja terapiju.

Calprotectin vs lactoferrin laboratory proteins shown beside an intestinal cross-section
Слика 1: dva markera stolice izvedena iz neutrofila prikazana pored sluznice debelog creva.

Za osobu sa 6 nedelja retke stolice, grčeva, bez gubitka težine ili rektalnog krvarenja, obično bih počeo sa kalprotektinom plus ciljanim testiranjem na infekciju umesto kolonoskopije. Rezultat ispod 50 µg/g čini značajnu upalu debelog creva manje verovatnom, dok jasno povišen rezultat daje razlog za dalju proveru. Smernice AGA za hroničnu vodenastu dijareju podržavaju kalprotektin ili laktoperoksidazu kao skrining testove za zapaljenske bolesti (Smalley et al., 2019).

Odaberite laktoperoksidazu kada vaša gastroenterološka služba dosledno koristi, kada laboratorija prijavi validiranu kvantitativnu vrednost, ili kada je uključena u rad na dijareji izazvanoj infekcijom. Nemojte je birati jer zvuči specifičnije: obe belančevine se oslobađaju kada neutrofili uđu u lumen creva. Praktično pitanje je da li vaš lekar može uporediti rezultat sa vašim prethodnim uzorcima koristeći istu analizu.

Кантести је АИ анализатор крви koja postavlja povezane rezultate kao što su hemoglobin, CRP, albumin i indeksi gvožđa uz izveštaj markera stolice; ne zamenjuje analizu stolice ili dijagnozu lekara. Ako se umor javlja uz dijareju, test krvi na dijareju može pomoći u identifikaciji dehidracije, anemije ili gubitka elektrolita koji utiču na hitnost.

Korisno pravilo

Prvo koristite jedan validovan marker, ponovite isti marker kada je rezultat graničan ili kada pratite terapiju, i sačuvajte dvostruko testiranje za specifično gastroenterološko pitanje. Promena analize na pola praćenja stvara prividne trendove koji mogu biti laboratorijski šum, a ne biologija.

Šta zapravo otkriva fekalni kalprotektin

Kalprotektin meri protein koji vezuje kalcijum i cink, a koji se uglavnom oslobađa iz neutrofila u crevnom traktu. Viša koncentracija u stolici odražava migraciju neutrofila u crevo, što je uobičajeno kod aktivnog IBD-a, ali se javlja i kod nekoliko ne-IBD stanja.

Fecal calprotectin test sample tray with an immunoassay cartridge in clinical laboratory
Слика 2: Radni postupak za kvantitativnu ekstrakciju stolice korišćen za merenje kalprotektina.

Kalprotektin je S100A8/S100A9 proteinski kompleks, i ostaje relativno stabilan u stolici nekoliko dana na sobnoj temperaturi - jedan je od razloga zašto dobro funkcioniše kao test za kućno prikupljanje. Njegova biološka prednost je lokalnost: za razliku od CRP-a, odražava ćelijsku aktivnost u lumenu creva, a ne sistemski odgovor akutne faze celog tela. Normalan CRP stoga ne isključuje visok rezultat kalprotektina.

U praksi odraslih, laboratorije obično klasifikuju manje od 50 µg/g kao normalno i više od 150–250 µg/g kao sve više kompatibilno sa aktivnom crevnom upalom. Ovo su pragovi odlučivanja, a ne univerzalne biološke granice. Neke evropske službe koriste 100 µg/g kao prag za upućivanje, dok se referentni intervali za pedijatriju i specifične analize mogu značajno razlikovati.

Video sam 28-godišnjaka sa kalprotektinom od 680 µg/g, normalnim CRP-om, i na kraju sa ulceroznim kolitisom ograničenim na rektum i sigmoidno debelo crevo. Taj obrazac nije neobičan: lokalna upala sluzokože može biti aktivna bez jakog sistemskog signala. Naša fecal calprotectin range guide explains why the laboratory’s own method and units should stay attached to every result.

Šta fekalni laktoferin otkriva drugačije

Lactoferrin detects another neutrophil-derived protein and answers nearly the same biological question as calprotectin: is there active intestinal neutrophil inflammation? It does not identify ulcerative colitis, Crohn’s disease, bacterial colitis, or another cause on its own.

Lactoferrin protein molecules near intestinal neutrophils in medical cellular illustration
Слика 3: Lactoferrin release from neutrophils during an intestinal tissue response.

Lactoferrin is an iron-binding glycoprotein stored in neutrophil secondary granules and released during activation. A positive qualitative fecal lactoferrin test is useful because it argues against uncomplicated IBS in the right clinical setting. Quantitative assays vary: one commonly used method defines a negative value as less than 7.25 µg/g, so never apply a calprotectin cutoff to a lactoferrin report.

The evidence does not show that lactoferrin is categorically superior. In a diagnostic meta-analysis, Wang and colleagues found fecal lactoferrin had pooled sensitivity of 82% and specificity of 95% for distinguishing IBD from non-IBD controls, although accuracy estimates shift with disease prevalence and study design (Wang et al., 2015). That impressive specificity still does not convert a positive result into an IBD diagnosis.

A positive lactoferrin result is especially worth discussing when diarrhoea began abruptly after travel, antibiotics, contaminated food exposure, or contact with someone unwell. In those situations, clinicians usually add pathogen testing rather than jumping straight to an IBD label. Our guide to rezultatima kulture stolice covers what a negative or mixed-growth report can and cannot settle.

Kako čitati granične vrednosti bez preterane reakcije

A calprotectin value below 50 µg/g is usually normal for adults, 50–150 µg/g is often an indeterminate zone, and values above 250 µg/g raise concern for active inflammation. Lactoferrin uses assay-specific cutoffs, commonly a qualitative positive or a quantitative threshold near 7.25 µg/g.

Calprotectin threshold comparison represented by stool assay wells and color gradation
Слика 4: Quantitative zones help guide retesting and referral decisions.

The 50 µg/g calprotectin threshold is designed for sensitivity: it catches most clinically significant inflammatory disease at the cost of some false positives. The 250 µg/g threshold is more useful for specificity and for monitoring established IBD. Between them lies the frustrating middle, where medication exposure, recent gastroenteritis, age, and trajectory matter more than a single number.

A change from 72 to 94 µg/g is often less meaningful than a change from 85 to 430 µg/g, particularly if both samples were tested by the same laboratory. Stool consistency can influence extraction and biological variation is real. Dr. Thomas Klein’s practical advice is to record NSAID use, recent infection, menstrual contamination, and collection date before interpreting a modest rise.

For a disciplined approach to serial values, compare the sample date with symptoms and related labs rather than treating every flagged result as disease progression. Our 3-10 mEq/L без калијума; 8-16 mEq/L са калијумом explains the same principle of reference change and analytic variation in laboratory medicine.

Obično ohrabrujuće <50 µg/g calprotectin Active colonic IBD is less likely in adults without alarm symptoms.
Гранична зона 50–150 µg/g calprotectin Review NSAIDs, infection and symptoms; repeat testing is often appropriate.
Jasno povišen 150–250 µg/g calprotectin Persistent elevation warrants clinical assessment and often further investigation.
Значајно повишено >250 µg/g calprotectin Suggests active mucosal inflammation but still requires cause-specific evaluation.

Zašto oba markera mogu biti povišena bez IBD

Elevated stool inflammation markers occur with enteric infection, NSAID exposure, diverticulitis, colorectal neoplasia, microscopic colitis and IBD. The result confirms an inflammatory signal; it does not disclose the cause, location, duration, or severity by itself.

Clinical consultation reviewing anti-inflammatory medication and a stool inflammation report
Слика 5: Medication history can materially alter interpretation of a raised marker.

Non-steroidal anti-inflammatory drugs can raise fecal calprotectin, sometimes substantially, by increasing intestinal permeability and causing small mucosal injuries. Ibuprofen, naproxen and diclofenac matter; a clinician may suggest withholding them if medically safe before repeating the test. Do not stop prescribed aspirin, anticoagulants, or pain medicines without asking the prescriber first.

Acute bacterial gastroenteritis may produce calprotectin values above 500 µg/g and a positive lactoferrin, which is why a stool pathogen panel can be more informative than an urgent colonoscopy in the first days of illness. Conversely, giardiasis may cause prolonged diarrhoea with less striking neutrophilic marker elevation. The symptom timeline often carries more diagnostic weight than patients expect.

Кантести је услузи за тумачење лабораторијских тестова заснованој на AI-у that can flag an inflammation pattern such as low hemoglobin, low albumin, thrombocytosis and raised CRP for clinician review, but those blood findings do not prove the source is intestinal. For people with blood in the stool, FIT follow-up and colonoscopy timing is a separate issue from calprotectin and should not be delayed.

Kada normalan rezultat i dalje može promašiti bolest

Normal calprotectin or lactoferrin makes active colonic inflammation less likely, but it cannot fully exclude Crohn’s disease, particularly mild or isolated small-bowel disease. A normal result also does not explain persistent weight loss, iron-deficiency anemia, nocturnal diarrhoea, or recurrent visible bleeding.

Small bowel cross-section showing patchy Crohn's disease activity beyond stool marker reach
Слика 6: Patchy small-bowel activity may produce a less conspicuous stool signal.

Small-bowel Crohn’s disease can shed less neutrophil protein into a stool sample than extensive colitis, especially when lesions are proximal or mild. This is one reason symptoms and alarm features overrule a reassuring number. The ECCO-ESGAR diagnostic guideline recommends integrating biomarkers with ileocolonoscopy and cross-sectional imaging when IBD remains clinically suspected (Maaser et al., 2019).

A 46-year-old with calprotectin of 38 µg/g, ferritin of 7 ng/mL, and progressive fatigue deserves evaluation for gastrointestinal blood loss or malabsorption even if bowel frequency is normal. In my experience, the combination of iron deficiency and unexplained symptoms is much more consequential than a single low stool marker. Read our low ferritin and gut clues for the usual next laboratory questions.

Celiac disease, bile acid diarrhoea, pancreatic insufficiency and many medication effects may cause symptoms with normal stool inflammation markers. A normal test is therefore a fork in the road toward non-inflammatory diagnoses, not a declaration that symptoms are psychological or unimportant.

Šta raditi sa graničnim rezultatom kalprotektina

A borderline fecal calprotectin result of 50–150 µg/g is commonly repeated after 2–6 weeks if symptoms are stable and there are no alarm features. The repeat should use the same laboratory method and should be timed away from a recent gastrointestinal infection where possible.

Home stool sample collection kit beside calendar and medication review notes
Слика 7: A repeat sample is most informative when collection conditions are documented.

Before retesting, clinicians review NSAIDs, proton-pump inhibitors, antibiotics, acute infections, strenuous endurance exercise and age-related risk. There is no universally agreed washout interval for every medicine. A pragmatic plan is often 2 weeks after an acute illness has settled, provided symptoms do not signal a need for earlier care.

If the repeat falls from 118 to 32 µg/g and symptoms settle, invasive testing may be avoidable. If it rises from 96 to 310 µg/g, the direction adds useful evidence even before an endoscopy result arrives. This is why a single borderline value should rarely trigger panic—or false reassurance.

Наше borderline calprotectin follow-up guide lays out the questions to bring to a primary-care or gastroenterology appointment. A short symptom diary with stool frequency, nighttime waking, fever and medication dates is usually more useful than obsessively checking food triggers.

Kako kliničari koriste markere nakon postavljanja dijagnoze IBD

In established IBD, calprotectin is most useful for tracking objective intestinal inflammation and helping decide whether symptoms represent a flare, infection, IBS overlap, or treatment failure. Lactoferrin can also follow activity, but calprotectin has more guideline-supported thresholds for treat-to-target monitoring.

Gastroenterology clinic reviewing stool biomarker trend cards alongside blood laboratory results
Слика 8: Serial biomarkers complement symptoms during IBD follow-up.

Symptoms and mucosal activity frequently diverge. A patient with ulcerative colitis may feel well while calprotectin climbs from 80 to 360 µg/g, or have urgent bowel motions from bile acid malabsorption while calprotectin remains 28 µg/g. The 2023 AGA ulcerative colitis biomarker guideline advises combining symptoms with biomarkers rather than relying on either alone (Singh et al., 2023).

For remission monitoring, many clinicians view less than 150 µg/g as reassuring, while more than 150 µg/g may warrant repeat testing, endoscopy, or treatment review depending on symptoms and prior disease behaviour. In active symptomatic ulcerative colitis, more than 250 µg/g supports ongoing inflammation. Cutoffs are guides, not instructions to alter biologic treatment without specialist input.

Kantesti AI je платформа за тумачење биомаркера помоћу AI that organizes blood-test trends around a patient’s reported treatment dates; it cannot assess stool endoscopic severity from a number alone. Patients taking biologics should also understand which blood safety tests monitor treatment and which symptoms require prompt contact with their IBD team.

Kako greške pri sakupljanju i tajming utiču na rezultate

Collection quality affects stool marker interpretation because a contaminated, delayed, or poorly sampled specimen can be rejected or produce a less reliable measurement. Most laboratories want a small stool portion placed into the supplied sterile container without toilet water or urine.

Hands placing stool sample into a sterile collection container using a clinical kit
Слика 9: Clean collection reduces preventable sample rejection and ambiguity.

Loose stool is usually acceptable for calprotectin and lactoferrin testing; do not wait for a formed sample if diarrhoea is the clinical problem. Avoid collecting from toilet water, and tell the laboratory if the sample includes visible menstrual blood. Storage instructions vary by kit, but many allow short room-temperature transport because calprotectin is comparatively stable.

Sampling a day after a marathon, a bout of gastroenteritis, or colonoscopy bowel preparation may answer the wrong question. Endurance exercise can transiently increase gut permeability and provoke gastrointestinal symptoms. If you are an endurance athlete without red flags, consider timing collection away from a major event; our vodiču za laboratorijske analize za sportiste izdržljivosti explains why context changes test interpretation.

The thing is, a perfect collection does not make a nonspecific biomarker specific. A high-quality sample improves confidence in the measurement; it cannot replace the clinical history, examination, and differential diagnosis.

Koji krvni testovi čine test stolice korisnijim

A CBC, CRP, ferritin, albumin, kidney function and celiac serology often add more clinical value to a raised stool marker than ordering a second stool inflammation protein. The concerning pattern is not any one abnormality but several results that point toward inflammation, malabsorption, or blood loss.

Laboratory blood panel results arranged with a calprotectin stool marker report
Слика 10: Blood markers add systemic context to an intestinal inflammation result.

Low hemoglobin, ferritin below 15 ng/mL, albumin below the laboratory reference range, raised platelets, or raised CRP can strengthen concern for clinically meaningful bowel disease. None is diagnostic of IBD. In fact, CRP may remain normal in mild ulcerative colitis, and ferritin can look falsely normal when inflammation raises it as an acute-phase protein.

Кантести је Алат за анализу крвних тестова уз помоћ AI that reads a CBC, iron studies and CRP in the same clinical frame, including whether a changing hemoglobin level might justify earlier review. Dr. Thomas Klein routinely cautions that an isolated CRP of 12 mg/L is nonspecific, whereas CRP 12 mg/L plus falling albumin and a calprotectin of 740 µg/g is a much more actionable cluster.

For patients whose iron values seem contradictory, our iron studies research guide explains transferrin saturation and ferritin during inflammation. A CBC result guide can also help you identify whether anemia is microcytic, inflammatory, or mixed.

Kada naručivanje oba testa može biti razumno

Ordering calprotectin and lactoferrin together is usually unnecessary, but it can be reasonable when a specialist is reconciling discordant symptoms, a prior assay cannot be repeated, or a local pathway requires confirmation. Concordant results modestly increase confidence in an inflammatory signal; discordant results usually trigger review, not arithmetic averaging.

Two separate stool inflammation assay cartridges compared in a gastroenterology laboratory
Слика 11: Different assay platforms should not be treated as interchangeable trend points.

A high calprotectin with negative lactoferrin may reflect assay timing, a result near the cutoff, specimen heterogeneity, or analytical differences. A low calprotectin with positive lactoferrin deserves the same disciplined response: verify collection, review the exact assay, check symptoms and test for infection when appropriate. Neither combination has a validated shortcut to diagnosis.

Dual testing can also be useful in research settings where a protocol prespecifies both biomarkers. That is different from routine patient care, where duplicate testing can add cost without improving decisions. Ask the ordering clinician a simple question: “What will we do differently if the second test is positive?”

If a report looks internally inconsistent, use our vodič za kvalitativno naspram kvantitativnog testa to understand why “positive” and “high” are not interchangeable laboratory statements. Consistency of method matters more than collecting every available marker.

Šta zapravo potvrđuje ili isključuje IBD

IBD is diagnosed through a synthesis of symptoms, ileocolonoscopy with tissue sampling, histology, laboratory tests, and sometimes MRI or CT enterography—not from calprotectin or lactoferrin alone. Stool markers help decide who needs these investigations and whether inflammation may be changing over time.

Ileocolonoscopy pathway represented by colon anatomy and clinical diagnostic instruments
Слика 12: Endoscopy and tissue examination establish the diagnosis beyond biomarker screening.

Colonoscopy allows direct assessment of the terminal ileum and colon and permits tissue examination for chronic inflammatory features, infection, microscopic colitis, dysplasia, and other causes. Imaging is particularly valuable when Crohn’s disease may involve small bowel beyond the reach of a standard colonoscopy. A stool marker is a triage signal, not a microscopic diagnosis.

Do not confuse a fecal immunochemical test with either inflammatory marker. FIT detects human hemoglobin and is used primarily in colorectal cancer screening or lower-GI bleeding pathways, whereas calprotectin and lactoferrin detect neutrophil products. Our comparison of FIT and FOBT explains why a negative inflammation marker does not substitute for recommended cancer screening.

As of September 4, 2026, no major gastroenterology guideline recommends diagnosing Crohn’s disease or ulcerative colitis from a single stool biomarker threshold. That restraint protects patients from both missed disease and unnecessary lifelong diagnostic labels.

Simptomi koji nadmašuju bilo koji rezultat testa stolice

Persistent visible rectal bleeding, black tarry stool, severe abdominal pain, fever, fainting, dehydration, rapidly worsening weakness, or unintended weight loss need timely medical assessment regardless of calprotectin or lactoferrin. A normal result should never be used to wait out a potentially urgent symptom pattern.

Patient symptom diary and urgent clinical assessment pathway in a calm medical setting
Слика 13: Alarm symptoms require clinical triage even when a stool marker is low.

The urgent concern is physiology, not the label on a laboratory report. Frequent watery diarrhoea can produce low potassium, acute kidney injury, and orthostatic symptoms before an inflammation marker returns. Adults with inability to keep fluids down, confusion, fainting, or minimal urine output should seek urgent care.

New bowel symptoms after age 50, a strong family history of colorectal cancer, and iron-deficiency anemia alter the threshold for colon evaluation even when calprotectin is low. A stool marker does not assess cancer risk comprehensively. Our mucus in stool red-flag guide distinguishes common benign patterns from symptoms that need examination.

Children, pregnant people, older adults, and people using immune-suppressing medicines need individualized triage because their baseline risks differ. If you are unsure whether symptoms are urgent, contacting a local clinician or urgent-care service is safer than trying to interpret a number in isolation.

Praktičan razgovor nakon Vašeg rezultata

The most useful follow-up question is: “Does this result change my need for infection testing, repeat testing, imaging, or endoscopy?” Bringing the exact value, assay name, symptom timeline, medicines, and previous results makes that conversation faster and more clinically precise.

Over-shoulder clinical discussion of stool inflammation results and symptom timeline
Слика 14: A structured symptom and medication history turns a biomarker into a decision.

Bring a list of the previous 14 days: stool frequency, overnight symptoms, fever, weight change, travel, antibiotics, NSAIDs, and family history. A calprotectin of 180 µg/g after a 3-day febrile diarrhoeal illness calls for a different plan than the same result after 4 months of nocturnal diarrhoea and weight loss.

Kantesti AI can help you organize accompanying blood reports before an appointment, but diagnosis and treatment decisions belong with the clinician who can examine you and arrange definitive testing. Our приступ медицинској валидацији explains how clinical oversight and source checking are built into responsible laboratory interpretation.

For complex cases, ask who will own the follow-up and when you should expect a repeat result or referral decision. The clinicians on our Медицински саветодавни одбор emphasize that a documented plan beats a vague instruction to “recheck later,” especially when inflammation markers and anemia move in the same direction.

Ključna poruka fokusirana na odluku

Choose calprotectin first in most settings, use lactoferrin when it is your service’s validated alternative, and do not assume either result diagnoses IBD. A low result shifts attention toward functional and non-inflammatory causes, while a persistently high result identifies people who may need infection testing, specialist review, or endoscopy.

For uncomplicated chronic diarrhoea, one normal marker—calprotectin below 50 µg/g or a negative lactoferrin according to that laboratory—can reduce the likelihood of active inflammatory disease. For a value above 250 µg/g or a positive lactoferrin with persistent symptoms, the next question is cause, not certainty. Infection, medicine exposure, IBD, and other inflammatory conditions remain on the list.

Most patients find the ambiguity hardest in the 50–150 µg/g calprotectin zone. In my experience, the best next step is usually a carefully timed repeat, not a dietary cleanse, self-directed steroid use, or an internet diagnosis. Keep the same laboratory where feasible so the trend is interpretable.

Kantesti’s Vodič kroz AI tehnologiju describes how our systems preserve laboratory context while highlighting questions for medical review. The safe use of any AI interpretation is the same here: use it to prepare for a better clinical conversation, never to override red flags or replace diagnostic care.

Често постављана питања

Da li je kalprotektin bolji od laktoferina u otkrivanju zapaljenskih bolesti creva?

Kalprotektin se obično preferira kod sumnje na IBD jer je široko dostupan kao kvantitativni test i ima uobičajene pragove za praćenje, kao što su manje od 50 µg/g i više od 250 µg/g. Laktoferin je takođe koristan marker izmeta dobijen iz neutrofila i može dobro da se pokaže kada laboratorija koristi validiran test. Nijedan marker ne potvrđuje IBD, jer infekcije, NSAIL, divertikulitis i druga crevna oboljenja mogu povisiti oba. Bolji test je obično onaj koji vaš lekar može da protumači zajedno sa simptomima i ponovi koristeći istu laboratorijsku metodu.

Какав ниво калпротектина је забрињавајући?

Nivo fekalnog kalprotektina ispod 50 µg/g je uglavnom ohrabrujući za odrasle osobe bez alarmantnih simptoma, dok se 50–150 µg/g često smatra graničnim i može se ponoviti nakon 2–6 nedelja. Vrednosti iznad 150–250 µg/g više ukazuju na crevnu upalu, a nivoi iznad 250 µg/g obično podstiču klinički pregled ili dalja ispitivanja. Tačna akcija zavisi od testa, simptoma, starosti, upotrebe NSAIL-a i da li vrednost raste. Vrednost od 600 µg/g nakon akutne bakterijske dijareje može imati drugačije značenje od 600 µg/g tokom nekoliko meseci hroničnih simptoma.

Da li IBS može uzrokovati visok kalprotektin ili laktorektin?

Некомпликовани синдром иритабилног црева обично не узрокује повишен фекални калпротектин или лактоферин јер СИБ не производи цревну упалу посредовану неутрофилима. Благе повишене вредности калпротектина између 50 и 150 µg/g могу се јавити услед недавне инфекције, употребе НСАИД-а, фактора повезаних са старењем или варијација у анализи, тако да не искључују аутоматски СИБ. Позитиван лактоферин или калпротектин изнад 250 µg/g требало би да подстакне процену инфламаторног или инфективног узрока, уместо да се претпостави СИБ. СИБ и ИБД могу постојати истовремено, што је још један разлог зашто симптоми и трендови имају значај.

Can a normal calprotectin rule out Crohn's disease?

Normalan nalaz kalprotektina umanjuje verovatnoću aktivne IBD (inflamatorne bolesti creva) u debelom crevu, ali ne može u potpunosti isključiti Kronovu bolest, naročito blagu ili izolovanu Kronovu bolest tankog creva. Vrednost ispod 50 µg/g ne bi trebalo da nadjača alarmantne faktore kao što su anemija zbog nedostatka gvožđa, gubitak težine, noćni proliv, uporno krvarenje ili jaka porodična istorija. Kliničari mogu koristiti ileokolonoskopiju, MR enterografiju ili kapsulnu endoskopiju kada klinička sumnja ostaje visoka. Rezultat je najbolje tretirati kao jedan od pokazatelja koji prilagođava verovatnoću, a ne kao konačni test isključenja.

Да ли треба да поновим гранични резултат калпротектина?

Granični rezultat kalprotektina od 50–150 µg/g se često ponavlja nakon 2–6 nedelja kada su simptomi stabilni i nema alarmantnih znakova. Pre ponavljanja, kliničari obično proveravaju nedavnuЕсли gastrointestinalnu infekciju, upotrebu NSAIL-a, antibiotika i uslove prikupljanja, jer svaki od njih može uticati na vrednost. Ako je moguće, koristite isti laboratorijski test, jer rezultati iz različitih metoda možda neće biti direktno uporedivi. Rastući rezultat ka 250 µg/g ili iznad generalno nosi veću kliničku težinu od stabilnog niskog povećanja.

Da li antibiotici mogu uticati na fekalni kalprotektin i laktoferin?

Антибиотици могу индиректно утицати на маркере инфламације у столици третирањем, покретањем или подударањем са инфективном дијарејом и променом цревног микробиома. Особа са дијарејом повезаном са антибиотицима треба да се процени на узроке као што је Clostridioides difficile, уместо да се повишен калпротектин или позитивна лактоферин тумаче као IBD. Не постоји поуздан универзалан број дана чекања након антибиотика пре тестирања; време зависи од симптома и клиничког питања. Перзистентна дијареја, грозница или бол у стомаку након антибиотика захтевају тестирање под вођством лекара, а не самолечење.

Укључите AI анализу крвне слике данас

Придружите се више од 2 милиона корисника широм света који верују Kantesti-у за тренутну и прецизну анализу лабораторијских тестова. Отпремите своје резултате крвне слике и добијте свеобухватно тумачење 15,000+ биомаркера за неколико секунди.

📚 Референциране научне публикације

1

Klein, T., Mitchell, S., & Weber, H. (2026). Kantesti LTD. (2026). Уробилиноген у тесту урина: Потпуни водич за уринализа 2026. Zenodo.. Kantesti AI Medical Research.

2

Klein, T., Mitchell, S., & Weber, H. (2026). Kantesti LTD. (2026). Iron Studies Guide: TIBC, Iron Saturation & Binding Capacity. Zenodo.. Kantesti AI Medical Research.

📖 Спољне медицинске референце

3

Smalley W et al. (2019). AGA Clinical Practice Guidelines on the Laboratory Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome in Adults.

4

Maaser C et al. (2019). ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications. Journal of Crohn's and Colitis.

5

Singh S et al. (2023). AGA Clinical Practice Guideline on the Role of Biomarkers for the Management of Ulcerative Colitis.

2 милиона+Анализирани тестови
127+Земље
75+Језици

⚕️ Медицинска одрицање одговорности

Е-Е-А-Т сигнали поверења

Искуство

Клиничка ревизија процеса тумачења лабораторијских налаза коју води лекар.

📋

Експертиза

Фокус на лабораторијску медицину: како се биомаркери понашају у клиничком контексту.

👤

Ауторитативност

Написао др Томас Клајн, уз рецензију др Саре Мичел и проф. др Ханса Вебера.

🛡️

Поузданост

Тумачење засновано на доказима, са јасним путевима праћења како би се смањила узнемиреност.

🏢 Кантести Д.О.О. Регистровaно у Енглеској и Велсу · Број компаније. 17090423 Лондон, Уједињено Краљевство · кантести.нет
blank
Од стране Prof. Dr. Thomas Klein

Др Томас Клајн је сертификовани клинички хематолог који обавља функцију главног медицинског службеника (Chief Medical Officer) у Kantesti AI. Са више од 15 година искуства у лабораторијској медицини и снажним интересовањем за тумачење резултата крвне слике уз подршку вештачке интелигенције, ради на повезивању нове технологије са свакодневном клиничком праксом. Његове области интересовања укључују анализу биомаркера, истраживање клиничке подршке одлучивању и оптимизацију референтних опсега специфичних за популацију. Као CMO, он даје клинички допринос интерном бенчмаркингу платформе и пружа клинички надзор над медицинским квалитетом едукативних извештаја компаније Kantesti.

Оставите одговор

Ваша адреса е-поште неће бити објављена. Неопходна поља су означена *